| Nr. | Year OPEN | Title | users say | rate good | rate bad | no link | Citation |
|---|
Medical ethicsSedationRosiglitazoneRegeneration of tissues and other biologic structuresCondomPre exposure prophylaxisDrug developmentGuidelinePediatrics| 1 | 1998 | Phenylketonuria--a problem in eugenics. | 
| + | - | nl | Ann Hum Genet 62(Pt 3):193-202 (1998) |
| 2 | 2005 | The sacred and the secular: the life and death of Terri Schiavo. |
| + | - | nl | CMAJ 172(9):1149, 1151 (2005) |
| 3 | 2003 | Dismantling the Helsinki declaration. |
| + | - | nl | CMAJ 169(10):997, 999 (2003) |
| 4 | 2002 | A systematic review and meta-analysis of studies comparing mortality rates of private for-profit and private not-for-profit hospitals. |
| + | - | nl | CMAJ 166(11):1399-406 (2002) |
| 5 | 2001 | Did the major clinical trials of statins affect prescribing behaviour? |
| + | - | nl | CMAJ 164(12):1695-6 (2001) |
| 6 | 2001 | Physicians and the pharmaceutical industry (update 2001). |
| + | - | nl | CMAJ 164(9):1339-44 (2001) |
| 7 | 2001 | Lessons from cisapride. |
| + | - | nl | CMAJ 164(9):1269, 1271 (2001) |
| 8 | 1995 | The breast cancer research scandal: addressing the issues. |
| + | - | nl | CMAJ 152(8):1195-7 (1995) |
| 9 | 2010 | An ethical hierarchy for decision making during medical emergencies. |
| + | - | nl | Ann Neurol 67(4):434-40 (2010) Lyden PD |
| 10 | 2007 | Time to ban direct-to-consumer prescription drug marketing. |
| + | - | nl | Ann Fam Med 5(2):101-4 (2007) |
| 11 | 2007 | AAFP supports improvement, not ban, on direct-to-consumer prescription drug ads. |
| + | - | nl | Ann Fam Med 5(2):180-1 (2007) |
| 12 | 2004 | Why do doctors use treatments that do not work? |
| + | - | nl | BMJ 328(7438):474-5 (2004) Doust J |
| 13 | 2003 | Review of abortion law demanded after abortion for cleft palate. |
| + | - | nl | BMJ 327(7426):1250 (2003) |
| 14 | 2003 | BMJ Publishing Group to launch an international campaign to promote academic medicine. |
| + | - | nl | BMJ 327(7422):1001-2 (2003) |
| 15 | 2003 | How to make a silk purse from a sow's ear--a comprehensive review of strategies to optimise data for corrupt managers and incompetent clinicians. |
| + | - | nl | BMJ 327(7429):1436-9 (2003) |
| 16 | 2007 | The Declaration of Helsinki. |
| + | - | nl | BMJ 335(7621):624-5 (2007) |
| 17 | 2007 | Euthanasia in neonates. |
| + | - | nl | BMJ 334(7600):912-3 (2007) |
| 18 | 2008 | Development of palliative care and legalisation of euthanasia: antagonism or synergy? |
| + | - | nl | BMJ 336(7649):864-7 (2008) |
| 19 | 2008 | Continuous deep sedation in patients nearing death. |
| + | - | nl | BMJ 336(7648):781-2 (2008) Murray SA |
| 20 | 2007 | Respiratory controversies in the critical care setting. When caring for critically ill patients, do clinicians have a responsibility to be innovative and try unproven approaches when accepted approaches are failing? |
| + | - | nl | Respir Care 52(4):408-15 (2007) |
| 21 | 2003 | Haemodialysis patients' views on their resuscitation status. |
| + | - | nl | Nephrol Dial Transplant 18(8):1644-7 (2003) |
| 22 | 2002 | End-of-life issues and the do-not-resuscitate order: who gives the order and what influences the decision? |
| + | - | nl | Chest 121(3):683-6 (2002) |
| 23 | 2007 | Point: the ethics of unilateral "do not resuscitate" orders: the role of "informed assent". |
| + | - | nl | Chest 132(3):748-51; discussion 755-6 (2007) |
| 24 | 2007 | Counterpoint: is it ethical to order "do not resuscitate" without patient consent? |
| + | - | nl | Chest 132(3):751-4; discussion 754-5 (2007) Manthous CA |
| 25 | 2010 | The rise and fall of rosiglitazone. |
| + | - | nl | Eur Heart J 31(7):773-6 (2010) Nissen SE |
| 26 | 2009 | Ethical issues in stem cell research. |
| + | - | nl | Endocr Rev 30(3):204-13 (2009) |
| 27 | 2011 | HIV pre-exposure prophylaxis (PrEP)--a quantitative ethics appraisal. |
| + | - | nl | PLoS One 6(8):e22497 (2011) |
| 28 | 2002 | Do not attempt resuscitation decisions in a cancer centre: addressing difficult ethical and communication issues. |
| + | - | nl | Br J Cancer 86(7):1057-60 (2002) |
| 29 | 2010 | End-of-life decision making in the intensive care unit. |
| + | - | nl | Am J Respir Crit Care Med 182(1):6-11 (2010) |
| 30 | 2010 | Lessons from the mammography wars. |
| + | - | nl | N Engl J Med 363(11):1076-9 (2010) |
| 31 | 2010 | Treating underinsurance. |
| + | - | nl | N Engl J Med 363(9):881-3 (2010) Perrin JM |
| 32 | 2010 | Revisiting the rosiglitazone story--lessons learned. |
| + | - | nl | N Engl J Med 363(9):803-6 (2010) |
| 33 | 2005 | The Groningen protocol--euthanasia in severely ill newborns. |
| + | - | nl | N Engl J Med 352(10):959-62 (2005) |
| 34 | 2010 | Drug research: marketing before evidence, sales before safety. |
| + | - | nl | Dtsch Arztebl Int 107(16):277-8 (2010) |
| 35 | 2002 | Bioethics for clinicians: 28. Protestant bioethics. |
| + | - | nl | CMAJ 166(3):339-43 (2002) |
| 36 | 2011 | Clinical practice guidelines as marketing tools. |
| + | - | nl | CMAJ 183(3):E141-2 (2011) |
| 37 | 2005 | Pharmaceutical advertisements in prescribing software: an analysis. |
| + | - | nl | Med J Aust 183(2):75-9 (2005) |
| 38 | 2007 | Mandatory fortification with folic acid - what would Hippocrates say? |
| + | - | nl | Aust Fam Physician 36(1-2):69-70, 72, 75 (2007) |
| 39 | 2007 | Conditional cash transfers for improving uptake of health interventions in low- and middle-income countries: a systematic review. |
| + | - | nl | JAMA 298(16):1900-10 (2007) |
| 40 | 2010 | Respiratory medicines for children: current evidence, unlicensed use and research priorities. |
| + | - | nl | Eur Respir J 35(2):247-65 (2010) |
| 41 | 2004 | Why I no longer accept pens (or other "gifts") from industry (and why you shouldn't either). | 
| + | - | nl | J Rheumatol 31(8):1478-82 (2004) |
| 42 | 2011 | Pricing and reimbursement of orphan drugs: the need for more transparency. |
| + | - | nl | Orphanet J Rare Dis 6(-):42 (2011) |
